TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

347.50$ -2.4% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Income Statement

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,705 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ONC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
220 18 33 53 54 59 78 243 50 57 52 66 91 100 606 150 206 214 307 342 388 380 448 595 781 634 752 929 1,002 1,128 1,117 1,315 1,412 1,498 1,513 1,705 6,129
30 29 43 47 90 94 114 171 156 267 194 247 257 18 14 14 21 21 33 36 47 49 65 71 77 74 82 96 96 106 125 138 170 161 165 165 197 142 167 175 681
-30 -29 -43 -47 131 -76 -82 -118 -102 -208 -116 -3.3 -207 39 38 51 70 79 573 114 159 165 241 270 311 307 366 499 685 529 627 791 831 967 952 1,151 1,216 1,356 1,346 1,531 5,448
30 29 43 47 88 91 110 164 148 257 178 229 237 283 304 286 349 356 321 356 352 430 390 378 426 446 409 423 453 494 461 454 496 542 482 525 524 615 541 612 2,293
4.7 8.3 8.8 11 16 27 29 45 49 72 58 82 105 366 417 427 444 455 505 459 538 529 555 555 593 2,233
4.7 8.3 8.8 11 16 28 29 45 49 73 58 83 105 427 412 410 510 564 503 589 621 737 685 710 749 775 737 818 819 912 888 898 951 1,047 941 1,063 1,053 1,171 1,096 1,205 4,525
-35 -37 -52 -58 115 -104 -111 -163 -151 -281 -174 -86 -312 -388 -374 -359 -440 -485 70 -475 -462 -572 -443 -439 -438 -469 -371 -319 -134 -384 -261 -107 -120 -79 11 88 163 185 250 325 923
0.3 0.0 0.2 2.0 1.8 0.5 1.6 1.9 4.6 6.0 4.5 2.9 2.2 0.4 6.7 1.1 0.6 5.2 4.2 4.9 2.2 4.5 10 11 13 18 7.0 8.0 58 33 40
-35 -38 -50 -60 114 -94 -109 -161 -145 -275 -168 -84 -312 -380 -363 -338 -435 -482 62 -481 -433 -587 -421 -558 -551 -431 -337 -367 229 -351 -243 -106 -98 -85 21 100 147 149 259 312 868
0.1 -0.3 0.2 0.2 -3.1 4.9 -3.4 -3.4 -0.5 -8.5 0.5 2.1 -3.2 7.6 1.6 -1.5 -8.4 -9.3 -4.6 -0.2 5.0 -1.2 14 8.1 6.3 14 11 14 14 17 7.7 14 23 67 20 5.2 22 83 32 75 212
-35 -38 -51 -61 117 -99 -105 -157 -144 -268 -168 -86 -307 -388 -364 -335 -425 -473 66 -480 -438 -586 -435 -566 -558 -445 -348 -381 215 -368 -251 -120 -121 -152 1.3 94 125 67 227 237 656
-34 -37 -51 -57 116 -102 -109 -161 -149 -277 -170 -82 -308 -381 -366 -351 -432 -477 80 -464 -419 -569 -405 -542 -535 -413 -317 -345 251 -327 -218 -82 -27 -35 61 135 184 249 333 393 1,159

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?